Martin Kappler

Expert Innovative Statistics Consultant

Martin Kappler, PhD, is an Expert Innovative Statistics Consultant in Strategic Consulting and has extensive experience with all statistical tasks related to the design, conduct, analysis, and reporting of clinical trials.

Martin has 25 years of experience as a statistician and has been working as a trial or lead statistician and expert statistical consultant for 20 years. During this time, he gained extensive experience in all statistical tasks related to the planning and designing, conducting and reporting of clinical trials. He contributed to the optimal design of clinical programs for regulatory submission and commercialization and was the study statistician for several late-phase submission projects. Martin participated and represented statistics in interactions with regulatory authorities (US, Europe, and national agencies). He participated in studies from all development phases as well as observational, real-world evidence, post-authorization safety studies, and registries using traditional frequentist methods or Bayesian analyses. He gained experience in a variety of therapeutic areas (oncology, immuno-oncology, immunology, hematology, endocrinology, hereditary disorders, neurology, gastroenterology, cardiovascular) with a special experience of around 20 studies in the context of rare diseases and small populations.

Prior to joining Cytel, Martin served as a Statistical Consulting Director at PRA Health Sciences, worked as independent statistical consultant at statαlpha, and as Senior Biostatistician at Novartis. Martin attended the University of Dortmund, Germany where he received his MSc in statistics and the University of Duisburg-Essen, Germany where he received his doctorate in medical sciences.